Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)
Small Molecules Studied
Download: Excel (XLSX), Comma-separated (CSV), Images (Zip file)
HMS LINCS ID | Name | Alternative Names | LINCS ID | Structure Image | PubChem CID |
---|---|---|---|---|---|
10236-1 | 17-AAG | Tanespimycin | LSM-43239 | 151069 | |
10501-1 | 2-deoxyglucose | 2-deoxy-D-glucose; 2-Desoxy-D-glucose; 2-DG | 9062 | ||
10237-1 | 5-DFUR | 5-FdUR; Doxifluridine | LSM-6359 | 18343 | |
10238-1 | 5-FU | Fluorouracil | LSM-4261 | 3385 | |
10133-2 | Afatinib | BIBW-2992 | LSM-43226 | 57519523 | |
10239-1 | AG1024 | Tyrphostin AG 1024 | LSM-4262 | 2044 | |
10223-2 | AG1478 | Tyrphostin | LSM-1224 | 2051 | |
10240-1 | AS-252424 | LSM-4263 | 56965900 | ||
10343-1 | Baicalein | LSM-6355 | 5281605 | ||
10241-4 | Bortezomib | Velcade | LSM-6281 | 387447 | |
10241-1 | Bortezomib | Velcade | LSM-6281 | 387447 | |
10189-2 | Bosutinib | SKI-606 | LSM-1190 | 5328940 | |
10502-1 | Bromopyruvic acid | 3-bromopyruvic acid; Bromopyruvate | 70684 | ||
10242-1 | Carboplatin | LSM-44959 | 5237030 | ||
10503-1 | Celecoxib | Celebrex; Celebra; Celecox; Onsenal; Solexa; SC-58635; YM-177 | 2662 | ||
10243-1 | CGC-11047 | PG11047 | LSM-4266 | 476863 | |
10504-1 | Chk2 inhibitor II | BML-277 | 9969021 | ||
10505-1 | Chloroquine | 2719 | |||
10245-1 | Cisplatin | CDDP; cis-Diaminodichloroplatinum; Cisplatinum; Lederplatin; Briplatin; Cismaplat | LSM-4268 | ||
10246-1 | CPT-11 | Irinotecan | LSM-2167 | 60838 | |
10232-2 | Dactolisib | BEZ235; NVP-BEZ235 | LSM-4255 | 11977753 | |
10506-1 | Dichloroacetate | 25975 | |||
10507-1 | Disulfiram | Tetraethylthiuram disulfide; TETD | 3117 | ||
10247-1 | Docetaxel | Taxotere | LSM-6360 | 148124 | |
10248-1 | Doxorubicin | Adriamycin | LSM-4062 | 31703 |